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Moebius syndrome (MS) is a congenital syndrome characterized by unilateral or bilateral
aplasia of the VI and VII cranial nerves, with consequent convergent strabismus and
bilateral peripheral facial paralysis. This syndrome might be associated with diurnal
excessive sleepiness and muscular hypotony, mimetizing in this manner, narcolepsy.
The diagnostic criteria for narcolepsy depend on the presence of REM sleep during the day. As
with patients with MS we do not have ocular movements due to the VI nerve paralysis, the
absence of horizontal ocular movements might make it difﬁcult to conﬁrm narcolepsy in
these patients. The common clinical characteristics of these patients are due to a possible
impairment of the same structures that are affected in the central nervous system. However,
the mechanism by which it occurs remains to be fully understood. Further electrophysiolo-
gical researches are necessary to better clarify the association of these two diseases. The
objective of this dissertation is to describe and discuss a case of Moebius syndrome with
diurnal excessive sleepiness as a differential diagnosis for narcolepsy.
& 2014 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Moebius syndrome (MS) is a congenital syndrome character-
ized by uni or bilateral aplasia of the VI and VII cranial nerves,
with subsequent convergent strabismus and bilateral facial
paralysis. Other cranial nerves might also be affected with
minor frequency as the IX and X nerves. Mental and psychotic
disturbances are also observed in these patients. MS might also
be the result of maternal exposure to drugs such as benzodia-
zepines or misoprostol during the 4th to 8th week of preg-
nancy. Anatomopathological studies have shown a nuclearep. Production and Hosti
licenses/by-nc-nd/3.0/).
-3.
29, Vila Clementino, CEP
(J. Castro).
an Association of Sleep.hypoplasia of the VI and VII nerves in patients with MS,
suggesting malformation of the brain stem. Image studies such
as cranial computerized tomography and nuclear magnetic
resonance might reveal signiﬁcant alterations in these patients
[1–3].
Authors point out that, at polysonogram, these patients do
not present REM sleep and there is the registry of low
amplitude electromyogram of the mandible during all the
sleep stages. The audible potential of the brain stem (APBS)
frequently show an elongation of the evoked potential waves
in this population with MS, indicating a dysfunction at theng by Elsevier B.V. This is an open access article under the CC BY-
04020-060, São Paulo, SP, Brazil. Tel.: þ55 11 59087191.
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diurnal excessive sleepiness (DES) and cataplexy, which
make it a differential diagnostic for narcolepsy [1].
Narcolepsy is a rare disease that may occur during any
age. The onset of symptoms appears between 15 and 25 years
of age. It is characterized by incontrollable attacks of sleep
(with frequent naps with REM sleep) during the day, being
classically described by an association between diurnal
excessive sleepiness, sleep fragmentation, cataplexy, sleep
paralysis and hypnagogic or hypnopompic hallucinations [4].
Although there is an association between the histocompat-
ibility complex DR2/DQB1n0602 and narcolepsy, its etiology
remains unknown. There are papers describing the symp-
toms of narcolepsy in patients with pathologies such as
temporal processes, brain vascular episodes or demyelinaza-
tion of the brain stem and diencephalon [5–7].
The objective of this case dissertation is to describe a case
of Moebius Syndrome and diurnal excessive sleepiness as a
differential diagnosis for narcolepsy.Table 1 – Polysonogram parameters.
Latency to begin sleep (min) 19.7
Latency to begin REM sleep (min) 407
Sleep efﬁciency (%) 77.5
Time awake after beginning of sleep (min) 89.2
Awakening index (events/h) 19.5
N1 (%) 27.4
N2 (%) 53.3
N3 (%) 16.2
REM (%) 3.1
IAH (events/h) 0
IDR (events/h) 0.3
SaO2 minimum (%) 97
Desaturation index (events/h) 0
Apnea and hypopnea indexes (AHI); Respiratory disorder index
(RDI); Arterial oxygen saturation arterial (SaO2).
Table 2 – Parameters of the sleep multiple latency test.
Averagea of sleep latencies (min) 7.7
Episodes of REM sleep during the test 0
a Average referred to 5 nap opportunities.2. Case dissertation
T.P.S., female, 21 years old, single, high school graduate,
unemployed, natural of São Paulo. She came to the outpatient
facility with complaints of loss of motor tonicity of major
muscle groups since the age of 5 years, worsening in the last
3 years. The frequency of the crisis varied from 2 to 6 times a
day and was precipitated by moments of intense emotion.
She also showed fragmented sleep, diurnal sleepiness
(Sleepiness Scale of Epworth 13), sleep paralysis, hypnagogic
hallucinations, somniloquy, somnambulism, nightmares, dif-
ﬁculty of concentration and memory reduction, besides irrit-
ability, snoring from 3 to 4 times a week, awakening with
suffocating sensation and body aches. She also referred
sleepiness during more hours than the usual.
Her sleep routine was marked by 3–4 awakening during
the night, waking up tired, invariably. She used to go to bed at
23 h and 30 min and wake up at 06 h and 00 min, taking
approximately 10 min to initiate sleep. Denied use of alcohol
or any other drugs. During the anamnesis, there were
identiﬁed episodes of anxiety and depression due to preju-
dice concerning her physical appearance. As comorbidities,
she also presented asthma and rhinitis. Family maternal
history of snoring and her grandmother showed sleep
apneas. She was being treated with inhaled budesonide,
nasal budesonide and loratadine.
Physically, her weight was of 56.8 Kg, height of 1.54m,
corporeal mass index (CMI) of 24.2 kg/m2, abdominal circum-
ference of 72 cm and cervical circumference of 31 cm. Demon-
strated Mallanpati II degree and tonsils grade I. Nasal
evaluation showed hypertrophy and pallor of the inferior nasal
cavities, septal deviation of II degree in the right area II. No
other alterations were observed and at neurological examina-
tion the patient demonstrated peripheral facial paralysis with
bilateral convergent strabismus. Brain magnetic resonance
revealed nonspeciﬁc ﬁndings. It were not characterized the
facial colliculi either the bilateral seventh cranial nerve. The
neurological exam demonstrated bilateral convergent strabis-
mus and bilateral peripheral paralysis.The polysonogram was followed by the test of multiple
sleep latencies (TMSL), together with the search for the alleles
HLA-DQB1n0602 and HLA-DR by PCR Duplex. The Epworth
Scale was equal to 17 (Tables 1 and 2). The research for the
allele HLA-DQB1n0602 was positive and the allele HLA-DR
was negative.
Although not all the traditional criteria for narcolepsy
were fully present, we began the treatment with methylphe-
nidate 5 mg in the morning and 5 mg in the afternoon, for a
month. The treatment chosen was based on the presence of
DES without any other identiﬁable causes and by the difﬁ-
culty in identifying the REM sleep on the electrophysiological
diagram in patients with MS. The patient was seen a last time
on February 10th, 2014 and was stable, with important
clinical improvements with the use of methylphenidate
20 mg per day and of amytriptilin 50 mg before bedtime.3. Discussion
Sleep disorders have been described and valued upon MS,
although the number of studies is still very small. An
evaluation of 19 participants demonstrated that all enrolled
patients with MS did refer some type of parasomnia, 50% of
them refer poor quality of sleep and 25% of these patients
with MS suffered from diurnal excessive sleepiness. Cata-
plexy was referred to by only 3 of these patients and only one
of them did show the allele HLA DQB1n0602. However, in this
study they did not perform polysonogram or the sleep multi-
ple latency test [2].
It is well known that the present diagnostic criteria for the
diagnostic f narcolepsy depend on the clinical ﬁndings and
electrophysiological studies. The diagnostic criteria for narco-
Fig. 1 – Epoch of REM sleep with multiple eye movement (ROC-A1 and LOC-A1).
Note: In patients with MS, there is no rapid eye movement, as seen at this time of the REM of a patient with normal ocular
motility.
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latencies of less than 8min and, at least, two episodes of REM
sleep during the ﬁve nap opportunities in adults [4].
It is also known that the REM sleep is characterized, among
other elements, by the rapid eye movement and muscle
hypotony (Fig. 1). The absence of horizontal eye movements
due to the paralysis of the VI nerves and the frequent muscle
hypotony of the mandible in these patients makes it very
difﬁcult to identify REM on their exams [3]. As a consequence,
we can underestimate the presence of REM on the polysono-
gram and sleep multiple latency tests, with the resulting
impossibility of reaching diagnostic criteria for narcolepsy.
In MS, we might ﬁnd necrosis in several areas of the brain
stem, stem and high vertebral stem hypoplasia, besides nuclear
agenesis of cranial nerves. Although the most accepted theory of
narcolepsy is the one of autoimmunity with destruction of the
hypocretin-producing cells in the hypothalamus, the physiology
of narcolepsy is still unclear [4]. Expansive processes of the
medium line such as craniopharyngiomas, vascular and demye-
linating lesions of the brain stem and hypothalamus have been
related to signs and symptoms of narcolepsy in some patients
[5,6,8]. These ﬁndings strengthen the importance of the brain
stem upon the physiopathology of these two entities. MS is
characterized by heterogeneous lesions in the brain stem and
high medulla spinalis [9]. This fact could explain the different
sleep complaints found among this population.The cataplexy attacks and other clinical characteristics of
narcolepsy of these patients are most likely a consequence of
the impairment of commonly affected structures on these two
illnesses. In theory, the structural alterations on the brain
stem region present in some of the patients with MS, would
lead to narcolepsy with cataplexy [1]. For the abovementioned
reasons, it becomes very difﬁcult to distinguish the symptoms
of sleepiness and cataplexy in the patients due to the con-
genital lesions observed in MS or to an associated narcolepsy.
Further studies must be conducted to better characterize the
affected areas in patients with MS and correlate them with the
symptoms of diurnal excessive sleepiness and cataplexy.r e f e r e n c e s
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